Tisdag 17 November | 06:40:18 Europe / Stockholm
Est. tid*
2027-02-26 08:00 Bokslutskommuniké 2026
2026-10-20 - Kvartalsrapport 2026-Q3
2026-07-21 - Kvartalsrapport 2026-Q2
2026-06-26 - Årsstämma
2026-05-08 - X-dag ordinarie utdelning PTRK 0.00 SEK
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag ordinarie utdelning PTRK 0.00 SEK
2025-06-27 - Årsstämma
2025-05-13 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-13 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning PTRK 0.00 SEK
2024-05-03 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2023-05-03 - Årsstämma
2023-05-02 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-26 - Kvartalsrapport 2022-Q1
2022-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2022-05-03 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-28 - Kvartalsrapport 2021-Q2
LandStorbritannien
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
Physitrack är verksamt inom hälsovårdssektorn och specialiserat inom sjukgymnastik. Produktportföljen inkluderar digitala vårderbjudanden till företag via SaaS-lösningar. Utöver huvudverksamheten erbjuds även personlig service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa och Nordamerika. Physitrack grundades år 2012 och har sitt huvudkontor i London.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Physitrack PLC — Transactions under Share Buy-back Programme

2026-11-16 08:30:00

Physitrack PLC (“Physitrack” or the “Company”) announces that, in connection with the share buy-back programme announced on 21 July 2026, the Company has repurchased its own ordinary shares during the period 9 – 13 November 2026, as set out below.

Summary of transactions

PeriodTotal shares repurchased during the weekVolume-weighted average price paid (SEK)Total consideration paid (SEK)Total shares held by the Company (treasury) following these transactionsTotal outstanding shares in the CompanyTreasury holding as % of issued share capital
9 – 13 November 20264,00011.141344,565.0480,43716,260,7660.49%

 
Individual transactions

DateQuantityAverage price (SEK)
9 November 202680010.8188
10 November 202680011.3000
11 November 202680011.1375
12 November 202680011.3000
13 November 202680011.1500

 
The share buy-back is carried out within the safe harbour under Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052. The purpose of the programme is to meet the Company's obligations under its employee share plans. The transactions are executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details

1. Issuer:Physitrack PLC; LEI 213800PC4QYNWHPCP774
2. Instrument/ISIN:Ordinary shares / GB00BYX22590
3. Trading venue:Nasdaq First North Growth Market Stockholm (PTRK)
4. Currency:SEK
5. Purpose:To meet the Company's obligations under its employee share plans, permitted under Article 5(2) of MAR
6. Executing broker:Pareto Securities, acting on a non-discretionary mandate

 
This disclosure is made in accordance with Article 5(3) of MAR and Commission Delegated Regulation (EU) 2016/1052.